Discovery of novel antimicrobial agents targeting the bacterial RNA polymerase by high-throughput virtual screening

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Bacterial RNA polymerase (RNAP) is the least popular target for antibiotics, and currently Rifampicin is only an approved drug for clinical use. However, RNAP is essential for bacterial growth and survival, and it can be a promising target for antimicrobial agents. Thus, we decided to search new antimicrobial agents for RNAP by virtual screening. When virtual screenings are performed, certain compounds repeatedly appears on hits covering a wide range of targets (frequently hitters). Also, the performance of hit generation is important factor in success of the virtual screening. Since we previously developed the optimized docking scores, we examined our scoring methods with rigorous removals of frequent hitters. We used two complex structures for RNAP, and also used two unrelated structures as negative controls to remove frequent hitters. Finally, we selected seven high-scored candidates from hits, and two of them showed the inhibition of Gram-positive bacteria by paper disk agar diffusion assay in vivo. © 2011 Chem-Bio Informatics Society.

Cite

CITATION STYLE

APA

Onodera, K., Kawasaki, T., & Kamijo, S. (2011). Discovery of novel antimicrobial agents targeting the bacterial RNA polymerase by high-throughput virtual screening. Chem-Bio Informatics Journal, 11(1), 52–56. https://doi.org/10.1273/cbij.11.52

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free